Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Other Products:

Generics Bulletin | Medtech Insight | In Vivo
Pink Sheet | HBW Insight | Report Store

Register

Sign In

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Existing Subscriber? Sign in to continue reading.

New to Scrip? Start a free trial today!

Register for our free email digests:

Existing Subscriber? Sign in to continue reading.

New to Scrip? Start a free trial today!

Register for our free email digests:

Email
Share

Sun Pharma acquires 14 prescription brands from Novartis

Mar 2016

Executive Summary

Sun Pharmaceutical Industries Ltd. acquired 14 prescription brands across various therapeutic areas from Novartis Pharma AG.

Deal Industry

Pharmaceuticals

Deal Status

Final

Deal Type

Alliance
- Product Purchase
- Marketing-Licensing
- Reverse Licensing

Already a Strategic Transactions subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com

Related Companies

Advertisement

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Sun Pharma acquires 14 prescription brands from Novartis

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice